ASCT

January 15, 2018January 15, 2018

Age Alone Should Not Exclude Lymphoma Patients From Stem Cell Transplants, Researchers Argue

News

Older lymphoma patients should not be excluded from treatment with stem cell transplants based solely on their age, researchers at Massachusetts General Hospital have concluded after reviewing several patient outcomes. The ... Read more

May 8, 2017May 8, 2017

Merck’s Keytruda Therapy for Certain Classical Hodgkin Lymphoma Patients Wins European Approval

News

The European Commission has approved the immune checkpoint inhibitor Keytruda (pembrolizumab) to treat certain Hodgkin lymphoma patients in 31 European countries, Merck announced. The approval applies to patients with relapsed or refractory classical ... Read more

May 31, 2016May 31, 2016

CHMP Favors Approval of Adcetris (brentuximab vedotin) to Treat Post-Transplant Hodgkin Lymphoma

News

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the extension of the present provisional approval of Takeda Pharmaceutical’s Adcetris (brentuximab ... Read more

February 16, 2016March 8, 2016

Negative-Data Clinical Trials in Lymphoma

To stay updated with the latest lymphoma clinical trials news, click here: http://bit.ly/1QoY2Uw Learn more about what happens after a lymphoma clinical trial ends here: http://bit.ly/1Rp5aB2